rs2296651
Positions:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_003049.4(SLC10A1):c.800C>T(p.Ser267Phe) variant causes a missense change. The variant allele was found at a frequency of 0.00173 in 1,613,510 control chromosomes in the GnomAD database, including 166 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0029 ( 18 hom., cov: 31)
Exomes 𝑓: 0.0016 ( 148 hom. )
Consequence
SLC10A1
NM_003049.4 missense
NM_003049.4 missense
Scores
10
8
Clinical Significance
Conservation
PhyloP100: 5.56
Genes affected
SLC10A1 (HGNC:10905): (solute carrier family 10 member 1) The protein encoded by this gene belongs to the sodium/bile acid cotransporter family, which are integral membrane glycoproteins that participate in the enterohepatic circulation of bile acids. Two homologous transporters are involved in the reabsorption of bile acids; the ileal sodium/bile acid cotransporter with an apical cell localization that absorbs bile acids from the intestinal lumen, bile duct and kidney, and the liver-specific sodium/bile acid cotransporter, represented by this protein, that is found in the basolateral membranes of hepatocytes. Bile acids are the catabolic product of cholesterol metabolism, hence this protein is important for cholesterol homeostasis. [provided by RefSeq, Oct 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.0052731335).
BP6
Variant 14-69778476-G-A is Benign according to our data. Variant chr14-69778476-G-A is described in ClinVar as [Benign]. Clinvar id is 501461.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-69778476-G-A is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.0642 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC10A1 | NM_003049.4 | c.800C>T | p.Ser267Phe | missense_variant | 4/5 | ENST00000216540.5 | NP_003040.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC10A1 | ENST00000216540.5 | c.800C>T | p.Ser267Phe | missense_variant | 4/5 | 1 | NM_003049.4 | ENSP00000216540.4 |
Frequencies
GnomAD3 genomes AF: 0.00297 AC: 452AN: 152184Hom.: 18 Cov.: 31
GnomAD3 genomes
AF:
AC:
452
AN:
152184
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00629 AC: 1579AN: 250862Hom.: 100 AF XY: 0.00558 AC XY: 756AN XY: 135604
GnomAD3 exomes
AF:
AC:
1579
AN:
250862
Hom.:
AF XY:
AC XY:
756
AN XY:
135604
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00160 AC: 2340AN: 1461208Hom.: 148 Cov.: 31 AF XY: 0.00141 AC XY: 1027AN XY: 726962
GnomAD4 exome
AF:
AC:
2340
AN:
1461208
Hom.:
Cov.:
31
AF XY:
AC XY:
1027
AN XY:
726962
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00295 AC: 449AN: 152302Hom.: 18 Cov.: 31 AF XY: 0.00299 AC XY: 223AN XY: 74462
GnomAD4 genome
AF:
AC:
449
AN:
152302
Hom.:
Cov.:
31
AF XY:
AC XY:
223
AN XY:
74462
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
0
ALSPAC
AF:
AC:
3
ESP6500AA
AF:
AC:
7
ESP6500EA
AF:
AC:
0
ExAC
AF:
AC:
689
Asia WGS
AF:
AC:
78
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Pathogenic:1Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Hypercholanemia, familial, 2 Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Dec 04, 2024 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Apr 18, 2017 | - - |
Hepatitis B virus, resistance to Benign:1
protective, no assertion criteria provided | literature only | OMIM | Dec 04, 2024 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T
MetaRNN
Benign
T
MetaSVM
Benign
T
MutationAssessor
Uncertain
M
PrimateAI
Benign
T
PROVEAN
Uncertain
D
REVEL
Uncertain
Sift
Uncertain
D
Sift4G
Uncertain
D
Polyphen
D
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at